Issue Date: August 22, 2016 | Web Date: August 21, 2016
Alcami to invest in Wisconsin site
The pharmaceutical services firm Alcami plans to introduce production of highly-potent active pharmaceutical ingredients at its facility in Germantown, Wis. Set for completion early next year, the project will add two highly-potent API suites that include up to 150 L of reactor capacity plus cryogenic capabilities, the firm says. Alcami, formed in 2013 through the merger of AAIPharma Services and Cambridge Major Laboratories, says the suites will be able to handle compounds with an occupational exposure limit of 0.03 µg/m3.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society